BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in GANX — Gain Therapeutics, Inc.
CIK 1107261
HOUSTON, TX
Position in GANX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,908
+$2,701 QoQ
Shares Held
30,004
0.0% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 49 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. GANX ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
552,566 | $13,372,097 | |
| 2 | INVA |
Innoviva, Inc.
|
350,253 | $7,954,245 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
791,616 | $6,420,005 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
124,184 | $4,858,078 | |
| 5 | EXEL |
Exelixis, Inc.
|
66,100 | $3,596,501 | |
| 6 | CRMD |
CorMedix Inc.
|
434,132 | $3,407,936 | |
| 7 | KROS |
Keros Therapeutics, Inc.
|
265,017 | $2,835,681 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,794,540 |
All Filings in GANX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,908 | 30,004 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $58,207 | 30,004 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $96,612 | 30,004 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $53,107 | 30,004 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $54,007 | 30,004 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $57,307 | 30,004 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $64,808 | 30,004 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $51,200 | 40,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $113,100 | 30,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $150,516 | 46,100 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $151,208 | 46,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $206,528 | 46,100 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $289,200 | 60,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $187,800 | 60,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $130,400 | 40,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $144,000 | 40,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $163,600 | 40,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $271,500 | 50,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $372,250 | 50,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $500,000 | 50,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||